Legal status in the United States
Is N-Acetyl Semax Amidate legal?
Read at FDA, DEA and WADAPublished by PepVault
N-Acetyl Semax Amidate has no FDA-approved product, is not a federally controlled substance, and is not named on WADA’s Prohibited List (from January 1, 2027, its S0 class names peptides in general), as of November 18, 2026.
N-Acetyl Semax Amidate at a glance
| Check | Status, read Nov 18, 2026 |
|---|---|
| FDA approval | Not approved |
| Compounding | Not named on FDA’s lists |
| DEA schedule | Not controlled |
| Sport (WADA) | Not named; from 2027, S0 names peptides in general |
FDA approval
N-acetyl Semax amidate has no FDA-approved product: Drugs@FDA lists no application for it.
- Drugs@FDA data (openFDA): applications listing “SEMAX” as an active ingredient, U.S. Food and Drug Administration. Read .

Compounding
FDA’s compounding lists don’t name it: not in any of the three 503A categories on FDA’s list updated May 14, 2026, not on FDA’s category 2 page, and not on the 503B bulks list.
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act (updated May 14, 2026), U.S. Food and Drug Administration. Read .
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks (content current as of April 22, 2026), U.S. Food and Drug Administration. Read .
- 503B Bulk Drug Substances List (content current as of May 16, 2024), U.S. Food and Drug Administration. Read .
DEA schedule
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
- 21 CFR Part 1308, Schedules of Controlled Substances (eCFR, up to date as of November 16, 2026), Electronic Code of Federal Regulations. Read .
- Controlled Substances, Alphabetical Order (dated November 17, 2026), Drug Enforcement Administration, Diversion Control Division. Read .
Sport (WADA)
Until December 31, 2026: The 2026 Prohibited List doesn’t name N-acetyl Semax amidate. Semax is built from a piece of ACTH, and S2.2.2 bans “corticotrophins and their releasing factors”; the list doesn’t say whether that reaches a fragment. S0 bans any substance not covered elsewhere on the list that has “no current approval by any governmental regulatory health authority for human therapeutic use”; whether that reaches it turns on its approval outside the United States, which this page doesn’t cover. From January 1, 2027: WADA’s 2027 list adds “peptides” to S0’s examples of non-approved substances, and its explanatory note says a peptide not named on the list “may still be prohibited”. It still doesn’t name N-acetyl Semax amidate, and whether S0 reaches it still turns on its approval outside the United States.
- World Anti-Doping Code International Standard, Prohibited List 2026 (in effect from January 1, 2026), World Anti-Doping Agency. Read .
- World Anti-Doping Code International Standard, Prohibited List 2027 (comes into effect on January 1, 2027), World Anti-Doping Agency. Read .
- Summary of Major Modifications and Explanatory Notes, 2027 Prohibited List, World Anti-Doping Agency. Read .
How it is sold when it isn’t approved
FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.
The source: falsely labeled “for research purposes” or “not for human consumption.”
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026), U.S. Food and Drug Administration. Read .
What this means and doesn’t
This page reports what the agencies’ own pages said about N-Acetyl Semax Amidate in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.
It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.
Questions
Is N-Acetyl Semax Amidate FDA approved?
N-acetyl Semax amidate has no FDA-approved product: Drugs@FDA lists no application for it.
Is N-Acetyl Semax Amidate a controlled substance?
It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.
Is N-Acetyl Semax Amidate banned in sport?
Until December 31, 2026: The 2026 Prohibited List doesn’t name N-acetyl Semax amidate. Semax is built from a piece of ACTH, and S2.2.2 bans “corticotrophins and their releasing factors”; the list doesn’t say whether that reaches a fragment. S0 bans any substance not covered elsewhere on the list that has “no current approval by any governmental regulatory health authority for human therapeutic use”; whether that reaches it turns on its approval outside the United States, which this page doesn’t cover. From January 1, 2027: WADA’s 2027 list adds “peptides” to S0’s examples of non-approved substances, and its explanatory note says a peptide not named on the list “may still be prohibited”. It still doesn’t name N-acetyl Semax amidate, and whether S0 reaches it still turns on its approval outside the United States.
What does FDA say about compounding N-Acetyl Semax Amidate?
FDA’s compounding lists don’t name it: not in any of the three 503A categories on FDA’s list updated May 14, 2026, not on FDA’s category 2 page, and not on the 503B bulks list.
What does FDA say about the “research use only” label?
FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.